Procalcitonin and Early Postoperative Infection After Pediatric Cardiopulmonary Bypass Surgery

Simona Silvetti1, Rosalba Lembo2, Alessio Mesini3

  • 1Neonatal and Pediatric Intensive Care Unit, Department of Surgery and Critical Care, IRCCS Istituto Giannina Gaslini, Genova, Italy.

Insights

Procalcitonin (PCT) measured 48 hours after pediatric cardiac surgery may help predict postoperative infections. This marker showed promise in identifying infections, unlike white blood cell count or C-reactive protein.

Area of Science:

  • Pediatric cardiac surgery
  • Infectious disease diagnostics
  • Biomarker research

Background:

  • Systemic inflammation and bacterial infections are common post-pediatric cardiac surgery.
  • Elevated white blood cell count and C-reactive protein lack specificity in early diagnosis.
  • Distinguishing infection from inflammation is crucial for timely treatment.

Purpose of the Study:

  • To evaluate procalcitonin (PCT) as a potential biomarker for early postoperative infection detection.
  • To assess PCT levels within 48 hours after pediatric cardiac surgery.
  • To compare PCT with traditional inflammatory markers.

Main Methods:

  • Retrospective observational study of 177 pediatric patients undergoing cardiac surgery.
  • Measurement of PCT, white blood cell count, and C-reactive protein at ICU admission, 24, and 48 hours post-surgery.
  • Recording of positive cultures within seven days post-surgery.

Main Results:

  • 12% of patients developed infections within seven days.
  • Procalcitonin (PCT) at 48 hours post-surgery was the sole laboratory predictor of infection (p=0.02).
  • Optimal PCT cut-off at 48 hours was 1.85 ng/mL, with AUC 0.63, sensitivity 63%, and specificity 69%.

Conclusions:

  • Procalcitonin (PCT) shows promise as a predictive marker for postoperative infections in pediatric cardiac surgery patients.
  • Further validation in larger cohorts is needed to confirm clinical relevance and predictive accuracy.
  • PCT may aid in differentiating infection from systemic inflammation.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
87
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
469
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
284